The University of Chicago Header Logo

Connection

Blase Polite to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Blase Polite has written about Dose-Response Relationship, Drug.
Blase Polite
Connection Strength
0.056
Dose-Response Relationship, Drug
  1. A UGT1A1 genotype-guided dosing study of modified FOLFIRINOX in previously untreated patients with advanced gastrointestinal malignancies. Cancer. 2019 05 15; 125(10):1629-1636.
    View in: PubMed
    Score: 0.030
  2. Genotype-Guided Dosing Study of FOLFIRI plus Bevacizumab in Patients with Metastatic Colorectal Cancer. Clin Cancer Res. 2017 Feb 15; 23(4):918-924.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.